Assessment of doubling dose of dexamethasone in progressively worsening severe COVID-19 pneumonia - a randomized controlled trial : Assessment of doubling dose of dexamethasone in progressively worsening severe COVID-19 pneumonia not responding to standard dose - an open-label pragmatic randomized controlled trial - ADDED

Media Type:

Clinical Trial

Year of Publication:

2021

Publication:

2021

Contained In:

WHO International Clinical Trials Registry Platform - (2021) vom: 07. Sept. To Main Record - year:2021

Language:

Unbestimmt

Links:

Volltext [kostenfrei]

Keywords:

610
Medical Condition: Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Phase: Phase 3
Recruitment Status: Not yet recruiting
Study Type: Interventional

Notes:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 19-08-2021, Last updated: 2021-09-13

PPN (Catalogue-ID):

WHO007869959